Originally Posted by
Beagle
Its hard to put a value on a company in a complete vacuum of information. Directors and the new private equity investor will know how they're trading year to date, 11 months to November and accordingly a very good idea on what the annual result will be for 2021 but shareholders are not even provided with proper interim financial statements. The lack of disclosure is disgraceful.
I have a revised value using my own methodology and appropriate discounting for lack of liquidity, lack of financial disclosure, risks, extended Covid influence, Aiora being withdrawn from Chemist Warehouse to name just some factors but its so far south of the recent share price I won't share it on here or bid at that price.
PAZ used to be on a PE of 20 and those that bought on that metric certainly have done extremely well. 20 x eps of 3 cps in 3 years time, (if achievable with Covid headwinds) = 60 cents 3 years hence. Discount that back to today's dollars using an appropriate discount rate for the risk and lack of liquidity. My updated 2 cents worth.